Pharmidex attending FENS Neuroscience conference
June 23, 2018
Pharmidex will be attending this years FENS neuroscience conference, where the CNS team will be presenting a poster.
Pharmidex will presenting "Dopamine metabolism in striatum, and rearing behaviour, suggest different significance on the attenuation of nicotine-induced changes on total locomotor activity for Varenicline and Baclofen."
The Abstract number for our presentation is F18-2414ABSTRACT. For more information please come and find our presentation as stated below!
Session Name: C. DISORDERS OF THE NERVOUS SYSTEM - C.15.l Psychiatric disorders: Addiction and drugs of abuse - part II
Date: 8 July 2018
Session Time: 14:00 - 17:30
Poster Board Number: C169
Pharmidex is proud to be exhibiting at the 36th BMCS Spring Symposium on Medicinal Chemistry, taking place today at the beautiful Fielder centre in Hatfield! 🏛️✨ We're excited to be part of this key gathering of thought leaders in drug discovery and development, sharing insights, connecting with fellow innovators, and shaping the future of medicinal chemistry. Our very own J anette Dalay Robertson is on-site and would be delighted to meet with attendees. Come say hello! She’s eager to discuss collaboration opportunities and explore how together we can accelerate breakthroughs in drug discovery and preclinical development. 💬 Let’s connect, innovate, and advance science, one molecule at a time.
This annual symposium is a key event in the medicinal chemistry calendar, bringing together researchers and industry professionals to discuss cutting-edge advances in drug discovery. Our team will be available to discuss how Pharmidex’s integrated services can support the development of novel therapeutics from early discovery through to candidate selection. 📍 Location: Hatfield, UK 📅 Date: 24th April 2025 🔗 www.pharmidex.com, https://lnkd.in/eZdCsd4M We look forward to engaging with the scientific community and exploring new opportunities for collaboration. Visit our stand or contact [email protected]. See you there!
We’re pleased to announce that Janette Dalay Robertson , our Business Development Manager, and Ian Knowles , our Head of Respiratory, will be attending the 2nd SMR Molecular Glues Meeting on Friday, 21st March 2025 at GSK, Stevenage. This event is a fantastic opportunity to engage with fellow scientists, innovators, and industry leaders in the field of molecular glues. Janette and Ian are eager to connect, share insights, and explore new collaborations to advance drug discovery and development. If you’re attending, don’t hesitate to reach out – they would love to meet and discuss how Pharmidex can support your research and development goals! 🔗 More about the event: https://lnkd.in/d6yiTkUi
